The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackrock Fr Regulatory News (BRFI)

Share Price Information for Blackrock Fr (BRFI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.00
Bid: 147.50
Ask: 150.50
Change: 0.00 (0.00%)
Spread: 3.00 (2.034%)
Open: 147.00
High: 0.00
Low: 0.00
Prev. Close: 147.00
BRFI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

25 May 2022 17:02

BlackRock Frontiers Investment Trust Plc - Portfolio Update

BlackRock Frontiers Investment Trust Plc - Portfolio Update

PR Newswire

London, May 25

The information contained in this release was correct as at 30 April 2022. Information on the Company’s up to date net asset values can be found on the London Stock Exchange Website at

https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html.

BLACKROCK FRONTIERS INVESTMENT TRUST PLC (LEI: 5493003K5E043LHLO706)

All information is at 30 April 2022 and unaudited.

Performance at month end with net income reinvested.

One month %Three months %One year %Three years %Five years %Since Launch* %
Sterling:
Share price5.46.714.011.414.0104.0
Net asset value5.27.123.426.733.2130.8
Benchmark (NR)**3.611.626.415.940.396.6
MSCI Frontiers Index (NR)2.0-0.89.824.532.486.8
MSCI Emerging Markets Index (NR)-1.0-4.3-9.911.027.357.3
US Dollars:
Share price0.6-0.23.37.210.765.0
Net asset value0.40.311.922.029.486.4
Benchmark (NR)**-1.24.414.611.636.259.6
MSCI Frontiers Index (NR)-2.7-7.1-0.419.928.550.4
MSCI Emerging Markets Index (NR)-5.6-10.5-18.36.923.526.7

Sources: BlackRock and Standard & Poor’s Micropal

* 17 December 2010.

** The Company’s benchmark changed from MSCI Frontier Markets Index to MSCI Emerging ex Selected Countries + Frontier Markets + Saudi Arabia Index (net total return, USD) effective 1/4/2018. 

At month end
US Dollar
Net asset value - capital only:186.41c
Net asset value - cum income:189.32c
Sterling:
Net asset value - capital only:148.48p
Net asset value - cum income:150.79p
Share price:135.50p
Total assets (including income):£285.5m
Discount to cum-income NAV:10.1%
Gearing:nil
Gearing range (as a % of gross assets):0-20%
Net yield*:3.1%
Ordinary shares in issue**:189,325,748
Ongoing charges***:1.4%
Ongoing charges plus taxation and performance fee:2.4%

\* The Company’s yield based on dividends announced in the last 12 months as at the date of the release of this announcement is 3.1% and includes the 2021 interim dividend of 2.75 cents per share, announced on 01 June 2021 and paid to shareholders on 25 June 2021. Also included is the 2021 final dividend of 4.25 cents per share, declared on 1 December 2021, and paid to shareholders on 11 February 2022.

** Excluding 52,497,053 ordinary shares held in treasury.

***Calculated as a percentage of average net assets and using expenses, excluding Performance fees and interest costs for the year ended 30 September 2021.

Sector AnalysisGross market value as a % of net assetsCountry AnalysisGross market value as a % of net assets
Financials34.9Saudi Arabia22.3
Industrials16.5Indonesia14.3
Consumer Discretionary15.0United Arab Emirates10.7
Materials14.0Vietnam8.8
Energy8.9Greece6.9
Consumer Staples6.5Thailand6.8
Real Estate6.1Malaysia5.4
Information Technology2.9Kazakhstan5.3
Utilities2.7Qatar4.7
Health Care1.7Hungary4.6
Communication Services1.4Philippines4.4
-----Egypt3.4
110.6Romania2.6
-----Chile2.4
Short positions-1.8Panama1.8
=====Kenya1.5
Poland1.4
Colombia1.3
Pakistan0.8
Peru0.5
Ukraine0.4
Nigeria0.3
-----
Total110.6
-----
Short positions-1.8
=====

*reflects gross market exposure from contracts for difference (CFDs).

Market Exposure 

31.05 2021 %30.06 2021 %31.07 2021 %31.08 2021 %30.09 2021 %31.10 2021 %30.11 2021 %31.12 2021 %31.01 2022 %28.02 2022 %31.03 2022 %30.04 2022 %
Long105.3106.8107.1104.2108.1110.6106.3104.3108.4110.7111.1110.6
Short 2.3 4.6 2.3 0.6 0.4 0.4 0.4 1.0 1.9 3.3 2.3 1.8
Gross107.6111.4109.4104.8108.5111.0106.7105.3110.3114.0113.4112.4
Net103.0102.2104.8103.6107.7110.2105.9103.3106.5107.4108.8108.8

Ten Largest Investments

CompanyCountry of RiskGross market value as a % of net assets
Saudi National BankSaudi Arabia5.4
Emaar PropertiesUnited Arab Emirates4.8
Bank RakyatIndonesia3.9
Saudi British BankSaudi Arabia3.6
Astra InternationalIndonesia3.2
Mobile WorldVietnam3.0
FPTVietnam2.9
United International TransportSaudi Arabia2.9
Yanbu National PetrochemicalSaudi Arabia2.8
National Bank of GreeceGreece2.6

 

Commenting on the markets, Sam Vecht and Emily Fletcher, representing the Investment Manager noted: 

The Company’s NAV returned +0.4% versus its benchmark the MSCI Emerging ex Selected Countries + Frontier Markets + Saudi Arabia Index (“Benchmark Index”), which fell by 1.2% in April. For reference, the MSCI Emerging Markets Index ended the month down 5.6% and the MSCI Frontier Markets Index returned -2.7% over the same period (all performance figures are on a US Dollar basis with net income reinvested).

The trend of divergence in performance between larger and smaller emerging markets continued in April. Over the past 12 months, the benchmark index has risen by +14.6% whilst the MSCI Emerging Markets index has fallen -18%. Frontier Markets have benefited from an acceleration of economic growth driven by reopening and attractive market valuations, whilst Emerging Markets have tumbled lower as markets priced in continued uncertainty from Russia-Ukraine dispute, an increasingly hawkish Fed, intensifying lockdowns in China, and dollar strength.

In our universe, country level performance was mixed. Kazakhstan bounced off its lows (+9.9%), Saudi Arabia (+5.9%) was another top performer, and Indonesia continued its rally this month, returning +3.7%. On the other side, Poland (-19%), Peru (-17%), and Chile (-12%) were challenged. Russia’s decision to cut off gas exports to Poland and Bulgaria was the key driver of performance in Eastern Europe. The risk of recession continues to loom large as we approach key deadlines for the EU and Russia to establish payment terms. In Latin America. In Chile, inflation is forcing the hand of the central bank to raise rates more steeply, with the most recent annual CPI print coming in at 9.4%.

The Company benefited from its exposure to the UAE, which has been buoyed by stronger commodity prices, economic recovery, and an influx of foreign capital as it rebrands itself from a transitory base to one that can be a permanent hub for expatriates. We’ve held positions in the UAE across a variety of sectors which all contributed positively. Air Arabia (+33%) was the biggest contributor driven by a rebound in tourism in the region. Emaar Properties (+9%) also did well driven by the booming property sector in UAE. We have seen a particularly strong recovery in the luxury segment volumes are ticking up, mortgages and residencies are being easier to obtain, and demand is resilient. Nitrogen fertilizer producer Fertiglobe (+3%) was another key contributor. The current high levels of European gas prices has pushed urea prices up around 150% over the past year, which coupled with the supply disruptions from Ukraine has benefited the company. Elsewhere, Indonesian auto conglomerate Astra International (+14%) did on coal price tightness continues and beta to domestic recovery. Kazakh super-app Kaspi (+30%) recovered after a sentiment-driven drawdown month in March despite strong earnings results.

On the other side, stock picks in Saudi Arabia detracted. Gym operator Leejam Sports (-12%) is seeing pressure on subscriber growth and pricing. National Medical Care (-7%) also detracted. In Egypt, our position in tobacco product name Eastern Company (-11%) hurt returns.

We made a few changes to the portfolio in April. We shifted our exposure in Thailand, exiting Kasikorn Bank as we look to reduce exposure to domestic Thailand in light of an expected inflation uptick and pressure on the central bank to raise rates against an already weak consumption backdrop. We also exited convenience store operator CP ALL on the same view and because we do not expect a full resumption of tourism this year as China holds onto to a strict zero COVID stance. We bought petrochemical name PTT Global to express a view on elevated refining spreads and compelling dividend yield. In Malaysia, we rotated out of Genting Berhad into Genting Malaysia as the latter has shown more capital discipline and a stronger balance sheet. We continue to expect a tourism and travel recovery (ex China) and as such, have upped positions in both Wizz Air and Copa Airlines. We also bought uranium producer Kazatamprom, the stock price has lagged the rally in uranium prices. We took profits across several names such as AKR Corpindo, Air Arabia, Fertiglobe, and Kaspi.

Overall, we are excited by the prospects of our portfolio. In an environment of high inflation, rising rates, and pressure on global Central Banks, frontier markets stack up favourably, and we would highlight the GCC where Current account and fiscal surpluses are on track to be the highest seen for 8 years. Valuations in fronter markets remain attractive relative to their own history and also relative to more developed markets. We believe our opportunity set is a compelling universe to generate alpha.

Sources:

1BlackRock as at 30 April 2022

2MSCI as at 30 April 2022

25 May 2022

ENDS

Latest information is available by typing www.blackrock.com/uk/brfi on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on BlackRock’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
26th Apr 202411:46 amPRNNet Asset Value(s)
25th Apr 202412:16 pmPRNNet Asset Value(s)
24th Apr 202412:16 pmPRNNet Asset Value(s)
23rd Apr 20241:15 pmPRNMandatory closed period - Compliance with Market Abuse Regulations
23rd Apr 202412:14 pmPRNNet Asset Value(s)
22nd Apr 202411:55 amPRNNet Asset Value(s)
22nd Apr 202411:46 amPRNDirector/PDMR Shareholding
19th Apr 202412:07 pmPRNNet Asset Value(s)
18th Apr 202412:17 pmPRNNet Asset Value(s)
17th Apr 202412:14 pmPRNNet Asset Value(s)
16th Apr 202412:03 pmPRNNet Asset Value(s)
16th Apr 202412:01 pmPRNPortfolio Update
15th Apr 202411:39 amPRNNet Asset Value(s)
12th Apr 202412:16 pmPRNNet Asset Value(s)
11th Apr 202412:12 pmPRNNet Asset Value(s)
10th Apr 202412:08 pmPRNNet Asset Value(s)
9th Apr 202411:46 amPRNNet Asset Value(s)
8th Apr 202412:00 pmPRNNet Asset Value(s)
5th Apr 202412:16 pmPRNNet Asset Value(s)
4th Apr 202412:04 pmPRNNet Asset Value(s)
3rd Apr 202412:09 pmPRNNet Asset Value(s)
3rd Apr 202410:53 amPRNPortfolio Update
2nd Apr 202412:09 pmPRNNet Asset Value(s)
2nd Apr 20247:00 amPRNTotal Voting Rights
28th Mar 202411:46 amPRNNet Asset Value(s)
27th Mar 202412:13 pmPRNNet Asset Value(s)
26th Mar 202412:05 pmPRNNet Asset Value(s)
25th Mar 20245:07 pmPRNPortfolio Update
25th Mar 202412:13 pmPRNNet Asset Value(s)
22nd Mar 202412:11 pmPRNNet Asset Value(s)
21st Mar 202412:18 pmPRNNet Asset Value(s)
20th Mar 202412:02 pmPRNNet Asset Value(s)
19th Mar 202411:49 amPRNNet Asset Value(s)
18th Mar 202412:14 pmPRNNet Asset Value(s)
15th Mar 202412:06 pmPRNNet Asset Value(s)
14th Mar 202412:19 pmPRNNet Asset Value(s)
13th Mar 202411:59 amPRNNet Asset Value(s)
12th Mar 202411:45 amPRNNet Asset Value(s)
11th Mar 202412:31 pmPRNNet Asset Value(s)
8th Mar 20241:03 pmPRNNet Asset Value(s)
7th Mar 202412:25 pmPRNNet Asset Value(s)
6th Mar 202412:23 pmPRNNet Asset Value(s)
5th Mar 202412:08 pmPRNNet Asset Value(s)
4th Mar 202411:46 amPRNNet Asset Value(s)
1st Mar 202411:59 amPRNNet Asset Value(s)
1st Mar 20247:00 amPRNTotal Voting Rights
29th Feb 202411:38 amPRNNet Asset Value(s)
28th Feb 202411:27 amPRNNet Asset Value(s)
27th Feb 202411:20 amPRNNet Asset Value(s)
26th Feb 202412:20 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.